BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30074643)

  • 1. A case-control study of the risk factors for developing aspergillosis following cardiac transplant.
    Cook JC; Cook A; Tran RH; Chang PP; Rodgers JE
    Clin Transplant; 2018 Sep; 32(9):e13367. PubMed ID: 30074643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pretransplant Aspergillus colonization of cystic fibrosis patients and the incidence of post-lung transplant invasive aspergillosis.
    Luong ML; Chaparro C; Stephenson A; Rotstein C; Singer LG; Waters V; Azad S; Keshavjee S; Tullis E; Husain S
    Transplantation; 2014 Feb; 97(3):351-7. PubMed ID: 24305637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
    Mattner F; Chaberny IF; Weissbrodt H; Fischer S; Gastmeier P; Haubitz B; Gottlieb J; Mattner L; Strueber M
    Mycoses; 2005; 48 Suppl 1():51-5. PubMed ID: 15826288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical risk factors for invasive aspergillosis in lung transplant recipients: Results of an international cohort study.
    Aguilar CA; Hamandi B; Fegbeutel C; Silveira FP; Verschuuren EA; Ussetti P; Chin-Hong PV; Sole A; Holmes-Liew C; Billaud EM; Grossi PA; Manuel O; Levine DJ; Barbers RG; Hadjiliadis D; Singer LG; Husain S
    J Heart Lung Transplant; 2018 Oct; 37(10):1226-1234. PubMed ID: 30139546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Voriconazole Exposure and Risk of Cutaneous Squamous Cell Carcinoma, Aspergillus Colonization, Invasive Aspergillosis and Death in Lung Transplant Recipients.
    Mansh M; Binstock M; Williams K; Hafeez F; Kim J; Glidden D; Boettger R; Hays S; Kukreja J; Golden J; Asgari MM; Chin-Hong P; Singer JP; Arron ST
    Am J Transplant; 2016 Jan; 16(1):262-70. PubMed ID: 26372838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted caspofungin prophylaxis for invasive aspergillosis in high-risk liver transplant recipients, a single-center experience.
    Chakravarti A; Butler-Laporte G; Carrier FM; Bilodeau M; Huard G; Corsilli D; Savard P; Luong ML
    Transpl Infect Dis; 2021 Aug; 23(4):e13568. PubMed ID: 33450126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of invasive fungal infections after liver transplantation and the risk factors of late-onset invasive aspergillosis.
    Nagao M; Fujimoto Y; Yamamoto M; Matsumura Y; Kaido T; Takakura S; Uemoto S; Ichiyama S
    J Infect Chemother; 2016 Feb; 22(2):84-9. PubMed ID: 26683245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of prior invasive aspergillosis on outcome in patients receiving reduced-intensity conditioning allogeneic hematopoietic stem cell transplant.
    El-Cheikh J; Castagna L; Wang L; Esterni B; Faucher C; Fürst S; Pierre B; Mohty M; Blaise D
    Leuk Lymphoma; 2010 Sep; 51(9):1705-10. PubMed ID: 20629522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practice variation in Aspergillus prophylaxis and treatment among lung transplant centers: a national survey.
    He SY; Makhzoumi ZH; Singer JP; Chin-Hong PV; Arron ST
    Transpl Infect Dis; 2015 Feb; 17(1):14-20. PubMed ID: 25620387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, risk factors and outcomes of invasive aspergillosis in solid organ transplant recipients in the Swiss Transplant Cohort Study.
    Neofytos D; Chatzis O; Nasioudis D; Boely Janke E; Doco Lecompte T; Garzoni C; Berger C; Cussini A; Boggian K; Khanna N; Manuel O; Mueller NJ; van Delden C;
    Transpl Infect Dis; 2018 Aug; 20(4):e12898. PubMed ID: 29668068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspergillosis caused by non-fumigatus Aspergillus species: risk factors and in vitro susceptibility compared with Aspergillus fumigatus.
    Torres HA; Rivero GA; Lewis RE; Hachem R; Raad II; Kontoyiannis DP
    Diagn Microbiol Infect Dis; 2003 May; 46(1):25-8. PubMed ID: 12742315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invasive aspergillosis caused by Aspergillus terreus: an emerging opportunistic infection with poor outcome independent of azole therapy.
    Hachem R; Gomes MZ; El Helou G; El Zakhem A; Kassis C; Ramos E; Jiang Y; Chaftari AM; Raad II
    J Antimicrob Chemother; 2014 Nov; 69(11):3148-55. PubMed ID: 25006241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants.
    Minari A; Husni R; Avery RK; Longworth DL; DeCamp M; Bertin M; Schilz R; Smedira N; Haug MT; Mehta A; Gordon SM
    Transpl Infect Dis; 2002 Dec; 4(4):195-200. PubMed ID: 12535262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly high-dose liposomal amphotericin B prevents invasive aspergillosis after heart transplantation.
    Cointault O; Joly M; Cassaing S; Labaste F; Danet C; Porte L; Guitard J; Kamar N; Faguer S;
    Transpl Infect Dis; 2021 Dec; 23(6):e13745. PubMed ID: 34657372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive aspergillosis in developing countries.
    Chakrabarti A; Chatterjee SS; Das A; Shivaprakash MR
    Med Mycol; 2011 Apr; 49 Suppl 1():S35-47. PubMed ID: 20718613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-years surveillance of invasive aspergillosis in a university hospital.
    Graf K; Khani SM; Ott E; Mattner F; Gastmeier P; Sohr D; Ziesing S; Chaberny IF
    BMC Infect Dis; 2011 Jun; 11():163. PubMed ID: 21651773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antifungal therapy and length of hospitalization in transplant patients with invasive aspergillosis.
    Baddley JW; Andes DR; Marr KA; Kauffman CA; Kontoyiannis DP; Ito JI; Schuster MG; Brizendine KD; Patterson TF; Lyon GM; Boeckh M; Oster RA; Chiller T; Pappas PG
    Med Mycol; 2013 Feb; 51(2):128-35. PubMed ID: 22680976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A risk profile for invasive aspergillosis in liver transplant recipients.
    Rosenhagen M; Feldhues R; Schmidt J; Hoppe-Tichy T; Geiss HK
    Infection; 2009 Aug; 37(4):313-9. PubMed ID: 19629387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Invasive aspergillosis among heart transplant recipients: a 24-year perspective.
    Muñoz P; Cerón I; Valerio M; Palomo J; Villa A; Eworo A; Fernández-Yáñez J; Guinea J; Bouza E
    J Heart Lung Transplant; 2014 Mar; 33(3):278-88. PubMed ID: 24559945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis.
    Kabbani D; Goldraich L; Ross H; Rotstein C; Husain S
    Transpl Infect Dis; 2018 Feb; 20(1):. PubMed ID: 29125713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.